Efficacy of fentanyl transdermal patch in pain control after lower third molar surgery: A preliminary study

Background Surgical removal of impacted lower third molars is a common oral surgical procedure, generally followed by moderate to severe postoperative pain. Transdermal drug delivery as a concept offers interesting possibilities for postoperative pain control. The aim of this study was to evaluate the efficacy of transdermal system with fentanyl in relieving pain following impacted lower third molar surgery. Material and Methods Seventeen patients with bilateral impacted lower third molars were included in this preliminary study. For postoperative pain control, patients randomly received a fentanyl patch plus placebo tablet after the first operation and regular (placebo) patch and an analgesic, after the second operation. Analgesia was evaluated during first 24 hours postoperatively according to patients’ reports about time of first pain appearance and additional analgesic consumption. Pain severity was rated using a 10 cm long visual analogue scale (VAS). Results Intensity of postoperative pain and postoperative analgesic consumption were significantly lower after the Fentanyl Transdermal System (FTS) was applied (p<0.05). Duration of postoperative analgesia was significantly higher with FTS when compared to control treatment (p<0.05). Conclusions Based on the results of this preliminary study, transdermal system with fentanyl significantly reduced postoperative pain after third molar surgery. Key words:Analgesia, fentanyl, transdermal administration, third molar surgery, acute pain, postoperative care.

[1]  J. Lötsch,et al.  Pharmacokinetics of Non-Intravenous Formulations of Fentanyl , 2012, Clinical Pharmacokinetics.

[2]  J. G. Reyes-García,et al.  Pre-emptive analgesic effectiveness of meloxicam versus tramadol after mandibular third molar surgery: a pilot study. , 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[3]  S. Schug,et al.  Formulations of Fentanyl for the Management of Pain , 2012, Drugs.

[4]  Lewis S. Nelson,et al.  Transdermal fentanyl: Pharmacology and toxicology , 2009, Journal of Medical Toxicology.

[5]  E. Viscusi,et al.  The Safety and Efficacy of Fentanyl Iontophoretic Transdermal System Compared with Morphine Intravenous Patient-Controlled Analgesia for Postoperative Pain Management: An Analysis of Pooled Data from Three Randomized, Active-Controlled Clinical Studies , 2007, Anesthesia and analgesia.

[6]  F. Coluzzi,et al.  Acute postoperative pain management: focus on iontophoretic transdermal fentanyl , 2007, Therapeutics and clinical risk management.

[7]  S. Culine,et al.  Inter- and Intraindividual Variabilities in Pharmacokinetics of Fentanyl After Repeated 72-Hour Transdermal Applications in Cancer Pain Patients , 2005, Therapeutic drug monitoring.

[8]  J. Chelly,et al.  An iontophoretic, fentanyl HCl patient-controlled transdermal system for acute postoperative pain management , 2005, Expert opinion on pharmacotherapy.

[9]  F. Chung,et al.  Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. , 2004, JAMA.

[10]  F. Nielsen,et al.  Dermal penetration of fentanyl: inter- and intraindividual variations. , 2003, Pharmacology & toxicology.

[11]  R. Williams,et al.  Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  P. Fine Fentanyl in the treatment of cancer pain. , 1997, Seminars in oncology.

[13]  L. Radbruch,et al.  Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region , 1997, Pain.

[14]  M. Tryba,et al.  Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain , 1996, Pain.

[15]  R. Seymour,et al.  The use of third molar surgery in clinical pharmacology. , 1993, The British journal of oral & maxillofacial surgery.

[16]  Suneel K. Gupta,et al.  System functionality and physicochemical model of fentanyl transdermal system. , 1992, Journal of pain and symptom management.

[17]  R. Seymour,et al.  Pain control after third molar surgery. , 1984, International journal of oral surgery.